| 1 |
He Y, Zhou Y, Wang H, Yin J, Chang Y, Hu P, Ren H, Xu H. Identifying potential biomarkers in hepatitis B virus infection and its response to the antiviral therapy by integrated bioinformatic analysis. J Cell Mol Med 2021;25:6558-72. [PMID: 34041839 DOI: 10.1111/jcmm.16655] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 2 |
Shawky H, El-Shenawy R, Helmy NM. Circulating macrophage inflammatory protein-1β/IL-12p40 ratio predicts sofosbuvir-based treatment outcome in HCV- genotype 4 patients. Hum Antibodies 2021. [PMID: 34511496 DOI: 10.3233/HAB-211504] [Reference Citation Analysis]
|
| 3 |
Han Z, Feng W, Hu R, Ge Q, Ma W, Zhang W, Xu S, Zhan B, Zhang L, Sun X, Zhou X. RNA-seq profiling reveals PBMC RNA as a potential biomarker for hepatocellular carcinoma. Sci Rep 2021;11:17797. [PMID: 34493740 DOI: 10.1038/s41598-021-96952-x] [Reference Citation Analysis]
|
| 4 |
Liu B, Che Y, Zhang M, Ren W, Xia X, Liu H, Huang T, Huang J, Lei L. IFN-γ Activates the TLR4-CCL5 Signaling Through Reducing Arginine Level, Leading to Enhanced Susceptibility of Bovine Mammary Epithelial Cells to Staphylococcus aureus. Inflammation 2020;43:2209-21. [PMID: 32725514 DOI: 10.1007/s10753-020-01288-9] [Reference Citation Analysis]
|
| 5 |
Zhong S, Zhang T, Tang L, Li Y. Cytokines and Chemokines in HBV Infection. Front Mol Biosci 2021;8:805625. [PMID: 34926586 DOI: 10.3389/fmolb.2021.805625] [Reference Citation Analysis]
|
| 6 |
Liu H, Wang L, Wang Y, Zhu Q, Aldo P, Ding J, Mor G, Liao A. Establishment and characterization of a new human first trimester Trophoblast cell line, AL07. Placenta 2020;100:122-32. [PMID: 32927240 DOI: 10.1016/j.placenta.2020.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Barathan M, Riazalhosseini B, Iyadorai T, Vellasamy KM, Vadivelu J, Chang LY, Zulpa AK, Larsson M, Shankar EM, Mohamed R. Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. Microb Pathog 2021;161:105231. [PMID: 34619310 DOI: 10.1016/j.micpath.2021.105231] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Rubio T, Felipo V, Tarazona S, Pastorelli R, Escudero-García D, Tosca J, Urios A, Conesa A, Montoliu C. Multi-omic analysis unveils biological pathways in peripheral immune system associated to minimal hepatic encephalopathy appearance in cirrhotic patients. Sci Rep 2021;11:1907. [PMID: 33479266 DOI: 10.1038/s41598-020-80941-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Zhu Z, Huang S, Zhang Y, Sun C, Tang Y, Zhao Q, Zhou Q, Ju W, He X. Bioinformatics analysis on multiple Gene Expression Omnibus datasets of the hepatitis B virus infection and its response to the interferon-alpha therapy. BMC Infect Dis 2020;20:84. [PMID: 31996147 DOI: 10.1186/s12879-019-4720-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
